NIH Funding Acknowledgement | Clinical & Translational Sciences

Use of any ICTS Core or Service requires the following NIH Funding Acknowledgement for all publications and projects.

“Research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.”

ICTS Scholars and Trainees, please note: ICTS grant-supported scholars and trainees should also reference the applicable NIH award number noted below for their direct career development/training support.

KL2TR002346 – ICTS Institutional Career Development Program
TL1TR002344 – ICTS Pre- and Post-doctorate Training Program

Questions may be directed to icts@wustl.edu or 314-362-9829.

Publication Requirements

PubMed Central ID (PMC ID) Registration

All investigators funded by the NIH, including those using ICTS services or receiving ICTS funding, must be compliant with the NIH Public Access Policy. This policy mandates that the author’s final version of any peer-reviewed journal article resulting from NIH-funded activities be submitted to the PubMed Central (PMC) repository. PMC reference numbers (PMCIDs) are part of the mandatory Public Access Law and are required for citation in future NIH grant applications. Lack of compliance with this law may result in a delay of Notices of Award for future grants. Any investigator submitting an application, proposal, or report to the NIH must include the PMCID when citing applicable papers.

Visit the WU Becker Medical Library for more information and support.

Note: A PMID alone is not compliant with Public Access Law.The PMCID is not the same as the PubMed ID (PMID).
- PubMed Central is an index of full-text papers and a PMCID links directly to the paper.
- PubMed is an index of abstracts and the PMID links to abstracts in PubMED.

ClinicalTrials.gov

Applicable clinical trials must be registered at ClinicalTrials.gov by federal law[KB1]. Clinical trials must be registered per the Food and Drug Administration Amendments Act, Section 801, or the NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information. Trials must be submitted to ClinicalTrials.gov no later than 21 calendar days following the study start (initiation) date. Studies that may be subject to the International Committee of Medical Journal Editors (ICMJE) Clinical Trial Registration Policy must be registered prior to informed consent of the first participant.

Note that the primary responsibility for registration of clinical trials and the posting of results resides with the Principal Investigator.

See the policies, procedures and guidelines for clinical trials registration and informed consent posting on the Office of the Vice Chancellor for Research website. To obtain a username and password for registration, email ccs@wustl.edu. For more information, contact Michelle Jenkerson, Associate Director of the Center for Clinical Studies, at 314-362-5626.

Other Support

Acknowledgement for COVID-19 Biorepository

Any publication that used samples from the Washington University COVID-19 biorepository must cite the following support:

“This study utilized samples obtained from the Washington University School of Medicine’s COVID-19 biorepository, which is supported by: The Foundation for Barnes-Jewish Hospital; the Siteman Cancer Center grant P30 CA091842 from the National Cancer Institute of the National Institutes of Health; and the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the view of the NIH.”